Rosacea is a common chronic inflammatory skin disorder that mainly affects the central face. Persistent redness is its hallmark; rosacea may also present as flushing, papules, and pustules. Its impact on patient well-being and social and emotional health is substantial, and systemic comorbidities may present further threats to patient well-being. Pharmacologic management is improving with the emergence of drugs that are more targeted to the pathogenesis of rosacea.
eNewsletter with interactive benchmarking
To educate clinicians on pharmacologic and nonpharmacologic management of rosacea, including new treatment options that recognize knowledge about the pathophysiology of the condition.
After completing this activity, participants should be better able to:
- Identify the pathophysiology and characteristics of rosacea in order to differentially diagnose it from other dermatologic diseases
- Select appropriate pharmacologic and nonpharmacologic treatment strategies for patients with rosacea based on individual patient factors and preferences
- Counsel patients on the proactive management of rosacea
Nurse practitioners and physician assistants in dermatology
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.0 contact hours under ANCC criteria.
This activity is provided for 0.5 hours related to pharmacotherapeutic content.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center’s Accreditation Program (ANCC). This distinction is valid through 2020.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Practicing Clinicians Exchange.
This program has been reviewed and is approved for a maximum of 1.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of April 27, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity was supported by an educational grant from Allergan, Inc.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, the American Academy of Physician Assistants, Continuing Education Alliance, Practicing Clinicians Exchange, or Allergan.
Accredited status as a provider of continuing nursing education refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center's Commission on Accreditation endorsement of any commercial supporters.
Please note that while the University of Nebraska Medical Center College of Nursing Continuing Nursing Education is an ANCC accredited organization, this does not imply endorsement by the UNMC or ANCC of any commercial products affiliated with this activity.
All faculty and planners participating in continuing education activities sponsored by the University of Nebraska Medical Center College of Nursing Continuing Nursing Education are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Please note that this activity may refer to use of products for a purpose other than which they were approved by the US Food and Drug Administration.
Dr Gallo: consultant: MatriSys, Sente.
Ms Sikes has nothing to disclose with regard to commercial interests.
The Planning Committee for this activity included Heidi Keeler, PhD, RN, of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education; Mark P. Christiansen, PhD, PA-C, of the University of the Pacific; and Ruth Cohen and Margaret Inman of Practicing Clinicians Exchange. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the eNewsletter in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: April 27, 2017
Expiration date: April 27, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. AGPCE91016